Nir Barzilai, MD vs Peter Diamandis, MD
What they share, where they diverge, and how the evidence compares — documented, not endorsed.
NB
Nir Barzilai, MD
2 compounds · longevity
Peter Diamandis, MD
22 compounds · longevity
Nir Barzilai, MD
2 Gated
🧬 Longevity & healthspan⚖️ Metabolic & weight
Peter Diamandis, MD
6 Strong8 Moderate3 Emerging5 Gated
🧬 Longevity & healthspan💪 Performance & recovery😌 Mood & stress🫀 Cardiovascular
Shared — both take (0)
0 of 24 distinct compounds overlap (0%).
No mapped compounds in common.
Only Nir Barzilai, MD (2)
- 🧬 Metformingated
- 💧 Empagliflozingated
Only Peter Diamandis, MD (22)
- ⏳ Rapamycingated
- 🩸 Rosuvastatin (Crestor)gated
- 🩸 Ezetimibe (Zetia)gated
- 🩸 Evolocumab (Repatha)gated
- ⚧️ Testosterone (TRT)gated
- ⏳ NMNModerate 5.5
- 🐟 Omega-3Strong 9.0
- ☀️ Vitamin D3Moderate 7.5
- ✨ MagnesiumStrong 8.5
- ⚡ B-ComplexModerate 6.5
- ⚡ CreatineStrong 9.5
- 💫 TaurineModerate 7.5
- ⚡ CoQ10Strong 8.0
- 🔋 PQQEmerging 4.5
- 🛡️ GlutathioneEmerging 4.8
- ⚡ Alpha Lipoic AcidModerate 7.0
- 🍊 Vitamin CStrong 8.0
- 🦐 AstaxanthinModerate 5.0
- 🌿 CurcuminModerate 7.5
- ⚡ DHEAModerate 5.5
- 🔄 PregnenoloneEmerging 4.5
- 🦠 ProbioticsStrong 9.0